Clorox (CLX) director adds deferred stock units through fees and awards

Rhea-AI Filing Summary

The Clorox Company director reports additional deferred stock units related to board compensation and dividend reinvestment. On November 6, 2025, the director acquired 199.1684 deferred stock units, each convertible into one share of Clorox common stock, at a price of $0.0000 per unit, bringing the total beneficially owned to 17,269.8302 units.

On December 31, 2025, the director received an additional 1,637.8577 deferred stock units as an annual award and 520.6784 deferred stock units in lieu of quarterly director fees, increasing total holdings to 19,428.3663 deferred stock units. These units are credited under Clorox’s independent director compensation plans and will be settled in Clorox stock when the director retires or otherwise leaves the board.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shattock Matthew J

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CA 94612-1888

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	11/06/2025		A(2)	V	199.1684		(3)	(3)	Common Stock	199.1684	$0.0000	17,269.8302	D
Deferred Stock Units	(1)	12/31/2025		A(4)		1,637.8577		(3)	(3)	Common Stock	1,637.8577	$0.0000	18,907.6879	D
Deferred Stock Units	(1)	12/31/2025		A(5)		520.6784		(3)	(3)	Common Stock	520.6784	$0.0000	19,428.3663	D

Explanation of Responses:

1. 1-for-1

2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

4. Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.

5. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.

	By Jinho Joo, Attorney-in-Fact	01/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Clorox (CLX) disclose in this Form 4?

The filing reports that a Clorox director acquired additional deferred stock units, which are derivative securities tied to Clorox common stock, as part of board compensation and dividend reinvestment programs.

How many deferred stock units does the Clorox (CLX) director own after these transactions?

Following the reported transactions, the director beneficially owns 19,428.3663 deferred stock units, each representing the right to receive one share of Clorox common stock in the future.

What transactions occurred on November 6, 2025 for Clorox (CLX) deferred stock units?

On November 6, 2025, the director acquired 199.1684 deferred stock units at a price of $0.0000 per unit, increasing total holdings to 17,269.8302 units. These units were acquired through dividend reinvestment under the Independent Directors' Deferred Compensation Plan.

What transactions occurred on December 31, 2025 for the Clorox (CLX) director?

On December 31, 2025, the director received 1,637.8577 deferred stock units as an annual award under the 2005 Stock Incentive Plan and 520.6784 deferred stock units in lieu of quarterly director fees.

How and when will the Clorox (CLX) deferred stock units be settled?

The filing states that the deferred stock units will be settled 100% in Clorox stock in connection with the director’s retirement or other termination of service as a member of the board.

What is the conversion ratio for the Clorox (CLX) deferred stock units?

The explanation notes a 1-for-1 relationship, meaning each deferred stock unit represents the right to receive one share of Clorox common stock when settled.